Chapter 1.       LUNG CANCER THERAPEUTICS MARKET       – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.       LUNG CANCER THERAPEUTICS MARKET        – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3.       LUNG CANCER THERAPEUTICS MARKET        – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.       LUNG CANCER THERAPEUTICS MARKET      - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5.       LUNG CANCER THERAPEUTICS MARKET       - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. LUNG CANCER THERAPEUTICS MARKET –  By Therapy

6.1. Targeted Therapy

6.2. Bevacizumab

6.3. Dabrafenib/Trametinib

6.4. Erlotinib Hydrochloride

6.5. Osimertinib 

6.6. Others

6.7. Immunotherapy

6.8. Durvalumab

6.9. Nivolumab

6.10. Atezolizumab

6.11. Pembrolizumab

6.12. Chemotherapy

Chapter 7.     LUNG CANCER THERAPEUTICS MARKET         –  By Cancer Type

7.1. Small cell lung cancer (SCLC)

7.2. Non-small cell lung cancer (NSCLC)

 Chapter 8.        LUNG CANCER THERAPEUTICS MARKET       – By Distribution Channel

8.1. Hospital Pharmacies

8.2. Online Pharmacies

8.3. Retail Pharmacies

8.4. Others

 Chapter 9.    LUNG CANCER THERAPEUTICS MARKET  – By Region

9.1. North America

9.2. Europe

9.3. Asia-P2acific

9.4. Latin America

9.5. The Middle East

9.6. Africa

Chapter 10.    LUNG CANCER THERAPEUTICS MARKET  – By Companies

10.1. Companies 1

10.2. Companies 2

10.3. Companies 3 

10.4. Companies 4

10.5. Companies 5

10.6. Companies 6

10.7. Companies 7

10.8. Companies 8

10.9. Companies 9

10.10. Companies 10